PRESENTATION: Optimising QC of oligonucleotides

PRESENTATION: Optimising QC of oligonucleotides

Presentation

Information

Oligonucleotides can vary significantly in structure, which makes them challenging to analyse. With the emergence of new oligonucleotide-based therapies, join this session to ensure your QC lab is equipped with the latest tool and knowledge on this emerging modality.

  • Design suitable characterisation and quality control strategies to overcome the difficulties associated with testing new oligonucleotide products.
  • Evaluate the options for oligonucleotide analysis including chromatography, mass spec and more.
  • Learn from real-world examples about tools/techniques/workflows to confirm identity and assess for impurities in your oligonucleotide products.
Agilent TechnologiesLet's bring great science to life Agilent supports scientists in 110 countries in cutting-edge life science research; patient diagnostics; and testing required to ensure the safety of water, food and pharmaceuticals. Our advanced instruments, software, consumables, and services enable our customers to produce the most accurate and reliable results as well as optimal scientific, economic, and operational outcomes. We play a role in advancing important research and testing, with our scientists creating some of the world's most leading-edge technology and our field engineers working side by side with customers to help them maximize productivity. We bring these solutions to a variety of markets, from pharma and diagnostics to applied materials and chemicals. Together with our customers, we’re bringing great science to life.

Log in